Organ support & nutrition

Aeromedical transport of patients receiving extracorporeal membrane oxygenation: a 12-year experience from a regional mobile extracorporeal Membrane Oxygenation (ECMO) network in the French Caribbean

Ann Intensive CarePublished Retrospective cohort study

Authors' conclusion

Aeromedical transport of critically-ill patients under ECMO support appears feasible and relatively safe in our experience, with a low incidence of serious adverse events.

Study context

Population
Patients supported with ECMO undergoing aeromedical transfer by a regional mobile ECMO network (University Hospital of Martinique), January 2010–December 2021of 520 ECMO patients
Participants
126 patients
Exposure
Intra-Caribbean vs transatlantic ECMO-supported aeromedical transfer
  • Intra-Caribbeann = 87reference
  • Transatlanticn = 39
Outcome
Transport-related adverse events (in-transfer complications)
Methodological detailsobservational, single-centre
  • Observational
  • Single-centre

Main finding

As reported in the abstract

In-transfer complications, all patients, mainly hemodynamic instability

18.3%

Transport-related deaths

1

Observational data: associations, not effects.

Further findings

In-hospital mortality

Overall in-hospital mortality
54.7%
No significant difference between intra-Caribbean and transatlantic patients

ECMO configuration

Veno-venous ECMO in intra-Caribbean transfers, mainly for ARDS
80.5%
Veno-arterial ECMO for refractory cardiogenic shock in transatlantic transfers
87.2%

Safety

In-transfer complications, mainly hemodynamic instability
18.3%
Transport-related death
1

Original publication

Aeromedical transport of patients receiving extracorporeal membrane oxygenation: a 12-year experience from a regional mobile ECMO network in the French Caribbean. Ann Intensive Care. Published 3 September 2026. doi:10.1016/j.aicoj.2026.100148

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.